Approval process

Institutional biosafety

Approval process

Applying for IBC review is a relatively straightforward process. Find out more about which pathway is most appropriate for your research, and the requirements for submission.

Step 1

Preparation

Before applying for Institutional Biosafety Committee (IBC) approval, you'll need to develop a well-considered research proposal/protocol. You may need to:

  • Seek review of the academic merit of your project
  • Complete all required risk assessments and safe work procedures
  • Consult with co-researchers/supervisors
  • Obtain necessary institutional approvals, including sign-off from your supervisor if necessary
  • Procure any necessary external documentation such as details of the organisms and vectors

Determine a timeline for the commencement of your research after approval.

See About the committee for agenda closing dates, for each meeting where applications will be considered.

Step 2

Submission

Email your application and supporting documentation to biosafety@csu.edu.au, ensuring all necessary signatures have been included.

All work with genetically modified organisms (GMOs) must:

The definition of a screened donor is that they show negative serology/virology for syphilis, Hepatitis B and C, and HIV.

Applications for an exemption to the Human Biological specimen's policy may be made to the IBC at any time via biosafety@csu.edu.au.

Confirmation of approvals from other compliance committees (for example, the Human Research Ethics Committee) must accompany the application. Names and contact details of all involved on the project together with confirmation that required vaccination/serological testing for those workers has been cited and recorded.

Applicants must provide sufficient information to enable the committee to make an informed decision.

If the applicant is applying for an ongoing exemption (for example, for some undergraduate practical classes), they shall nominate the period (session times) for such exemptions (for a maximum of three years).

The Australian Standard AS/NZS 2243.3:2010 classifies infectious microorganisms into risk groups by microorganism type (e.g. viruses, bacteria, parasites, fungi) and further divides the lists into human/animal, plant and invertebrate infectious microorganisms. Safe work practices and physical containment levels for each group are also detailed within the standard.

List of Risk Group 2, 3 and 4 organisms

When planning to purchase or acquire Micro-organisms of Risk Group 2 and above you need to submit an application form to the Institutional Biosafety Committee for approval.

Step 3

Outcome

Approval will be notified in writing following the IBC meeting. Your approval will contain an approval reference number.

Work may only commence once you've received your written approval from the IBC. Work must be conducted only in approved laboratories or in an area or manner approved by the IBC.Once your application has been reviewed by the Biosafety committee, you'll receive one of the following outcomes for your application:

  • Further information response –this requires you to answer the questions in order to obtain approval
  • Resubmission - the application will need to be revised and resubmitted for another review
  • Approval –you can commence your research